Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$166.06 USD

166.06
965,423

+0.96 (0.58%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $165.82 -0.24 (-0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 4% (10 out of 252)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for UHS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Universal Health Services, Inc. [UHS]

Reports for Purchase

Showing records 421 - 440 ( 443 total )

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 421

03/18/2014

Daily Note

Pages: 10

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 422

03/18/2014

Company Report

Pages: 8

Upgrading to BUY; Recent Pullback Offers a Buying Opportunity

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 423

02/28/2014

Company Report

Pages: 7

Few Surprises in 4Q; Maintaining our 2014-2015 EPS Estimates

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 424

02/27/2014

Daily Note

Pages: 3

4Q Slightly Light on Volume Softness & Cost Report Adj.

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 425

01/14/2014

Industry Report

Pages: 10

Health Care Facilities: 2014 Outlook and Top Picks

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 426

10/30/2013

Company Report

Pages: 6

Solid Quarter but Restating EPS Estimates to Remove HITECH Impact

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 427

10/29/2013

Daily Note

Pages: 4

Quick Alert: 3Q Ahead Ex. DSH Catch-Up as Acute Care Volumes Rebound

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 428

07/26/2013

Company Report

Pages: 8

2Q: Acute Care Growth & Mix Shows Improvement

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 429

07/25/2013

Daily Note

Pages: 4

2Q First Look-EPS Ahead Better than Expected

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 430

07/11/2013

Daily Note

Pages: 18

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 431

07/10/2013

Company Report

Pages: 16

Initiating Coverage with HOLD Rating

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 432

07/10/2013

Daily Note

Pages: 120

Health Care Sector Research-Initiating Coverage

Provider: KEYBANC CAPITAL MARKETS

Price: 150.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 433

06/07/2012

Daily Note

Pages: 5

Termination of Coverage

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 434

06/04/2012

Company Report

Pages: 5

UHS to Further Expand its Behavioral Footprint through the Acquisition of Ascend Health Services

Provider: AURIGA USA

Analyst: LOSEV G

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 435

04/27/2012

Company Report

Pages: 5

1Q12: Acute Trends Improve, but Margin Pressure Forces EPS Miss; Robust Growth in Behavioral Continues

Provider: AURIGA USA

Analyst: LOSEV G

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 436

03/20/2012

Company Report

Pages: 5

Flu Activity Down Y/Y; Non-Flu IP Volumes Increase; Las Vegas'' Improving

Provider: AURIGA USA

Analyst: LOSEV G

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 437

02/28/2012

Company Report

Pages: 6

4Q11 In-Line; 2012 Guidance Appears Conservative; Maintain Buy; Raise PT to $51

Provider: AURIGA USA

Analyst: LOSEV G

Price: 25.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 438

10/28/2011

Company Report

Pages: 5

3Q11 Review: Quarter In-Line with Expectations; Continued Solid Behavioral Business Overshadows Softness in Acute

Provider: AURIGA USA

Analyst: LOSEV G

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 439

10/12/2011

Company Report

Pages: 5

3Q Preview: No Change to Revenue, EPS Outlook; Reiterate Buy

Provider: AURIGA USA

Analyst: LOSEV G

Price: 10.00

Research Provided by a Third Party

Company: Universal Health Services, Inc.

Industry: Medical - Hospital

Record: 440

08/24/2011

Company Report

Pages: 16

Initiating Coverage with a Buy Rating and a $45 Price Target

Provider: AURIGA USA

Analyst: LOSEV G

Price: 50.00

Research Provided by a Third Party